367 related articles for article (PubMed ID: 12554432)
41. Approach to risk assessment of PCDDs and PCDFs in Canada.
Feeley MM; Grant DL
Regul Toxicol Pharmacol; 1993 Dec; 18(3):428-37. PubMed ID: 8128004
[TBL] [Abstract][Full Text] [Related]
42. Comparisons of estimated human body burdens of dioxinlike chemicals and TCDD body burdens in experimentally exposed animals.
DeVito MJ; Birnbaum LS; Farland WH; Gasiewicz TA
Environ Health Perspect; 1995 Sep; 103(9):820-31. PubMed ID: 7498094
[TBL] [Abstract][Full Text] [Related]
43. Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration.
Willhite CC; Ball GL; McLellan CJ
J Toxicol Environ Health B Crit Rev; 2008 Feb; 11(2):69-146. PubMed ID: 18188738
[TBL] [Abstract][Full Text] [Related]
44. Impact of physiologically based pharmacokinetic modeling on benchmark dose calculations for TCDD-induced biochemical responses.
Kim AH; Kohn MC; Portier CJ; Walker NJ
Regul Toxicol Pharmacol; 2002 Dec; 36(3):287-96. PubMed ID: 12473413
[TBL] [Abstract][Full Text] [Related]
45. Application of qualitative and quantitative uncertainty assessment tools in developing ranges of plausible toxicity values for 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Wikoff D; Haws L; Ring C; Budinsky R
J Appl Toxicol; 2019 Sep; 39(9):1293-1310. PubMed ID: 31257608
[TBL] [Abstract][Full Text] [Related]
46. Significant issues raised by meta-analyses of cancer mortality and dioxin exposure.
Starr TB
Environ Health Perspect; 2003 Sep; 111(12):1443-7. PubMed ID: 12948881
[TBL] [Abstract][Full Text] [Related]
47. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
[TBL] [Abstract][Full Text] [Related]
48. Blood lipid concentrations of dioxins and dibenzofurans causing chloracne.
Coenraads PJ; Olie K; Tang NJ
Br J Dermatol; 1999 Oct; 141(4):694-7. PubMed ID: 10583118
[TBL] [Abstract][Full Text] [Related]
49. Reflections on the assessment of the toxicity of "dioxins" for humans, using data from experimental and epidemiological studies.
Neubert D
Teratog Carcinog Mutagen; 1997-1998; 17(4-5):157-215. PubMed ID: 9508730
[TBL] [Abstract][Full Text] [Related]
50. [Political poisoning with dioxins--a weapon of chemical "disgracefulness"].
Finkelstein A; Rotman E; Eisenkraft A; Krivoy A; Laish I; Tashma Z; Hoffman A; Yehezkelli Y
Harefuah; 2005 Oct; 144(10):729-35, 749. PubMed ID: 16281767
[TBL] [Abstract][Full Text] [Related]
51. Public health assessment for dioxins exposure from soil.
Pohl H; DeRosa C; Holler J
Chemosphere; 1995 Jul; 31(1):2437-54. PubMed ID: 7670858
[TBL] [Abstract][Full Text] [Related]
52. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
[TBL] [Abstract][Full Text] [Related]
53. 2,3,7,8-Tetrachlorodibenzo-p-dioxin: environmental contaminant and molecular probe.
Poland A; Kende A
Fed Proc; 1976 Oct; 35(12):2404-11. PubMed ID: 134910
[TBL] [Abstract][Full Text] [Related]
54. Mortality experience of employees exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Cook RR; Townsend JC; Ott MG; Silverstein LG
J Occup Med; 1980 Aug; 22(8):530-2. PubMed ID: 6447199
[TBL] [Abstract][Full Text] [Related]
55. The diagnosis of dioxin-associated illness.
Webb KB; Ayres SM; Mikes J; Evans RG
Am J Prev Med; 1986; 2(2):103-8. PubMed ID: 2968809
[TBL] [Abstract][Full Text] [Related]
56. Commentary on 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD).
Mofenson H; Becker C; Kimbrough R; Lawrence R; Lovejoy F; Winters W; Carracio TR; Hardel LK; Rumack BH; Spyker D
Vet Hum Toxicol; 1985 Oct; 27(5):434-8. PubMed ID: 4060565
[TBL] [Abstract][Full Text] [Related]
57. Dioxin-induced chloracne--reconstructing the cellular and molecular mechanisms of a classic environmental disease.
Panteleyev AA; Bickers DR
Exp Dermatol; 2006 Sep; 15(9):705-30. PubMed ID: 16881967
[TBL] [Abstract][Full Text] [Related]
58. [Why is dioxin harmful?].
Huitfeldt HS; Lindeman B; Skarpen E; Oksvold MP; Wierød L
Tidsskr Nor Laegeforen; 1999 Nov; 119(29):4323-8. PubMed ID: 10667131
[TBL] [Abstract][Full Text] [Related]
59. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on murine heart development: alteration in fetal and postnatal cardiac growth, and postnatal cardiac chronotropy.
Thackaberry EA; Nunez BA; Ivnitski-Steele ID; Friggins M; Walker MK
Toxicol Sci; 2005 Nov; 88(1):242-9. PubMed ID: 16120746
[TBL] [Abstract][Full Text] [Related]
60. A critical evaluation of the use of mutagenesis, carcinogenesis, and tumor promotion data in a cancer risk assessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Shu HP; Paustenbach DJ; Murray FJ
Regul Toxicol Pharmacol; 1987 Mar; 7(1):57-88. PubMed ID: 3575798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
